Immunovant Halted Lupus Drug Trial
The clinical-stage firm ended development of IMVT-1402 after failing to meet the primary endpoint in a recent study.
Live Poll
Do you trust pharmaceutical companies to prioritize patients when deciding to cancel drug development programs?
